CTT Pharmaceutical Holdings, Inc. (CTTH)
CTTH Stock Price Chart
Explore CTT Pharmaceutical Holdings, Inc. interactive price chart. Choose custom timeframes to analyze CTTH price movements and trends.
CTTH Company Profile
Discover essential business fundamentals and corporate details for CTT Pharmaceutical Holdings, Inc. (CTTH) to support your stock research and investment decisions.
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
IPO Date
21 Apr 1997
Employees
2.00
CEO
Ryan Khouri
Description
CTT Pharmaceutical Holdings, Inc. engages in the development of oral drug delivery systems for pain management and treatment. It focuses on fast dissolving drug delivery systems. The company's technology platform includes the development of advanced oral delivery thin wafers infused with both natural and/or synthetic cannabis extracts to deliver treatment as an alternate to smoking and ingestion. Its principal asset is a patented orally administered wafer, an orally administrable wafer comprising at least one physiologically acceptable film forming agent. The company was formerly known as Mindesta Inc. and changed its name to CTT Pharmaceutical Holdings, Inc. in July 2015. The company is based in Ottawa, Canada.
CTTH Financial Timeline
Browse a chronological timeline of CTT Pharmaceutical Holdings, Inc. corporate events including earnings releases, dividend announcements, and stock splits.
CTTH Stock Performance
Access detailed CTTH performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.
Explore Related Stocks
Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.